Inhibrx Inc
About
Inhibrx Inc (NASDAQ:INBX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer
Apr 20 2026
Inhibrx To Host Webcast Presentation to Provide Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer
Mar 19 2026
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Mar 2 2026
Inhibrx Announces Participation in Upcoming Scientific Conference
Dec 16 2025
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program
Financials
Revenue
$1.3 M
Market Cap
$930.76 M
EPS
-9.04